tiprankstipranks
Truist Financial Keeps Their Hold Rating on DaVita (DVA)
Blurbs

Truist Financial Keeps Their Hold Rating on DaVita (DVA)

In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on DaVita (DVAResearch Report), with a price target of $150.00. The company’s shares closed yesterday at $137.01.

According to TipRanks, S Macdonald is a 5-star analyst with an average return of 13.1% and a 64.58% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Radnet, Cigna, and Option Care Health.

Currently, the analyst consensus on DaVita is a Hold with an average price target of $142.00, representing a 3.64% upside. In a report released on May 6, Barclays also maintained a Hold rating on the stock with a $150.00 price target.

Based on DaVita’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.15 billion and a net profit of $150.67 million. In comparison, last year the company earned a revenue of $2.92 billion and had a net profit of $68.1 million

Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is neutral on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

DaVita (DVA) Company Description:

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles